← All stocks

Arbutus Biopharma Corp

ABUS No buying or selling
CIK 0001447028 #2587 in the set updated 22 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions

There is no salary here to measure against. Arbutus Biopharma Corp's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
McElhaugh Michael J.
Interim President & CEO
1,658,003
0.8380%
$5.44M
+10.2%
HASTINGS DAVID C
Chief Financial Officer
249,824
0.1263%
$820.17K
+37.3%
Sims Karen
Chief Medical Officer
155,494
0.0786%
$510.49K
+23.9%
Naftzger J. Christopher
General Counsel and CCO
140,544
0.0710%
$461.41K
+44.0%
Nguyen Tuan
Chief Financial Officer
73,500
0.0371%
$241.30K
Androski Lindsay
President and CEO
28,000
0.0142%
$91.92K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 101,500
History held since 6 Oct 2016